Picture of Anika Therapeutics logo

ANIK Anika Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Anika Reports Q4 Earnings Per Share $0.28

Feb 20 (Reuters) - Anika Therapeutics Inc  ANIK.O :
    * ANIKA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL
RESULTS
    * Q4 EARNINGS PER SHARE $0.28
    * SEES FY 2020 REVENUE $160 MILLION TO $165 MILLION
    * Q4 REVENUE $29.8 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$27.6
MILLION
    * Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.43 EXCLUDING
ITEMS
    * Q4 EARNINGS PER SHARE ESTIMATE $0.42 -- REFINITIV IBES
DATA
    * ANIKA THERAPEUTICS - TOTAL REVENUE FOR Q4 OF 2019
INCREASED 10%
YEAR-OVER-YEAR TO $29.8 MILLION, COMPARED TO $27.0 MILLION FOR
Q4 OF 2018
    * ANIKA THERAPEUTICS - CO EXPECTS TOTAL REVENUE TO BE IN
RANGE OF
$160 MILLION TO $165 MILLION FOR THE FULL YEAR OF 2020
    * ANIKA THERAPEUTICS - CAPITAL EXPENDITURES ARE EXPECTED TO
BE
BETWEEN $5 MILLION AND $7 MILLION FOR 2020

Source text for Eikon:  ID:nGNX4ctPR3 
Further company coverage:  ANIK.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Anika Therapeutics

See all news